Received Aug 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
dermatomyositis; This serious case was reported by a consumer via interactive digital media and described the occurrence of dermatomyositis in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, immediately after receiving Shingles vaccine, the patient experienced dermatomyositis (Verbatim: dermatomyositis) (serious criteria GSK medically significant). The outcome of the dermatomyositis was not reported. It was unknown if the reporter considered the dermatomyositis to be related to Shingles vaccine. The company considered the dermatomyositis to be unrelated to Shingles vaccine. Additional Information: GSK Receipt Date: 25-JUL-2025 This case was reported by a patient via interactive digital media. The patient had a shingles shot and got dermatomyositis an autoimmune disease shortly after it's like lupus.; Sender's Comments: A case of Dermatomyositis, immediately after receiving Shingles vaccine, in a patient. Based on the available information a possible causality that the events were caused by the GSK product cannot be ascertained. Consent for further follow up has not been received.